Ergoloid Mesylates USP For Compounding (API)

Ergoloid Mesylates USP for Compounding (API) is an active pharmaceutical ingredient used in the preparation of custom medications, particularly in specialized compounding pharmacy settings. It is a combination of three ergot alkaloids and is primarily utilized for its vasodilatory and neuroprotective properties. Ergoloid mesylates are often prescribed to manage symptoms associated with cognitive decline and age-related memory disorders, helping improve mental function and mood in elderly patients. By enhancing cerebral blood flow and neurotransmitter function, it may contribute to reducing signs of dementia or other cognitive impairments.

Ergoloid Mesylates USP is an active pharmaceutical ingredient used in compounding for its cognitive and neuroprotective properties. It is a combination of three ergot alkaloids (dihydroergocornine, dihydroergocristine, and dihydroergocryptine) and has been shown to improve blood flow and oxygen utilization in the brain, leading to enhanced cognitive function. It is commonly used in the treatment of age-related cognitive decline, Alzheimer's disease, and vascular dementia. It may also help with symptoms of vertigo and balance disorders.

Ergoloid Mesylates USP is used to improve cognitive function and behavior in individuals with mental decline, primarily those with Alzheimer's disease and age-related cognitive decline. It may also be used to treat symptoms of vertigo, such as dizziness and balance problems, as well as to improve blood circulation.